Drug Profile
Research programme: dihydrocostatolide - National Cancer Institute/Sarawak MediChem
Alternative Names: (-)-Dihydrocalanolide B; 7,8-Dihydrocostatolide; Dihydrocodstatolide; NSC 661123Latest Information Update: 02 Mar 2009
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA)
- Class Antivirals; Coumarins; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections